CymaBay Therapeutics, Inc.

DRIEHAUS CAPITAL MANAGEMENT LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

841,677

Value ($000)

19,880

Weight

0.2%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	19,880	0.2%	841,677	12/31/2023